Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Absorptiometry, Photon × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 2 Wilms Tumor 1 Sarcoma, Ewing 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hepatoblastoma 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Carcinoma In Situ 1

Interventions

Specimen Handling 5 Tamoxifen 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 2 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Telemedicine 1 Starch 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Genotype 1 Gels 1 Educational Status 1 Early Intervention, Educational 1 Diet Therapy 1 Diet 1 Biopsy 1 Behavior Therapy 1 Anesthesia, General 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671912 2026-03-04

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡